Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
CapsoVision, IncBullish
CapsoVision announced that its AI-assisted reading tool, 'AI Highlights', for the CapsoCam Plus system received FDA clearance on September 25, 2026. This tool is designed to assist physicians in reviewing small bowel capsule endoscopy studies by automatically identifying and highlighting suspected abnormal lesions to improve diagnostic efficiency.…more
CapsoVision, Inc
Insider Eliyahou Harari of CapsoVision, Inc reported a change in beneficial ownership of securities effective September 18, 2026. This filing serves as the official disclosure of the insider's equity transaction via SEC Form 4.…more
CapsoVision, Inc
Insider Shen Ching Hang of CapsoVision, Inc has filed an amended Form 4/A regarding changes in beneficial ownership of securities originally reported on April 17, 2026. This filing serves as an administrative correction to the insider's reported holdings.…more
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
CapsoVision to Present at the 20th Annual LD Micro Main Event
CapsoVision announced that its management team will present at the 20th Annual LD Micro Main Event on October 21, 2026. This participation in an investor conference is a routine corporate event and does not provide immediate financial catalysts.…more
●●●●●●●● ●●●●● ●●●●●●
CapsoVision has received FDA clearance for its AI Highlights tool, designed to assist physicians in reviewing small bowel capsule endoscopy images. This technology aims to improve clinical efficiency by automatically identifying and prioritizing suspected lesions.…more
●●●●●●●● ●●●●● ●●●●●●
CapsoVision will issue 3,163,444 shares of common stock at $5.69 per share to raise approximately $17.83 million in net proceeds. This offering to existing shareholders will result in equity dilution for current investors.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.